Viewing Study NCT02628132

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2026-02-25 @ 11:01 PM
Study NCT ID: NCT02628132
Status: COMPLETED
Last Update Posted: 2020-07-07
First Post: 2015-11-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients
Sponsor: King Faisal Specialist Hospital & Research Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None triple negative View
None breast cancer View
None durvalumab View
None paclitaxel View
None safety View
None efficacy View
None PD-L1 View
None PD-1 View
None Metastatic View
None AstraZeneca View
None MEDI4736 View